INF2 and focal segmental glomerulosclerosis: Although the effects of pathogenic INF2 on other signaling pathways regulated by INF2, such as the Hippo pathway and the Rho GTPase-DIAPH signaling pathway, have not yet been explored, it is conceivable that these pathways may also be disrupted, potentially contributing to the pathogenesis of FSGS.